A leading biotechnology provider set a corporate goal to slash emissions throughout its operations. Part of that initiative,\u00a0driven\u00a0through its involvement in the EV100 initiative, is to convert its sales fleet of more than 1,300 vehicles to\u00a0electric vehicles (EVs)\u00a0by 2030, translating to an ambitious move toward vehicle electrification.<\/p>\r\n\r\n\r\n\r\n
It has already made enormous strides toward its company-wide objective, implementing electrification and solar energy onsite with electric buses, solar-powered charging stations and green-certified buildings on campus.\u00a0\u00a0<\/p>\r\n\r\n\r\n\r\n
For the\u00a0field,\u00a0it\u00a0transitioned\u00a0to a combination\u00a0of hybrid\u00a0vehicles, plug-in\u00a0hybrid electric\u00a0vehicles\u00a0(PHEV), and full\u00a0battery-electric\u00a0vehicles\u00a0(BEV) until\u00a0it’s\u00a0possible for the entire fleet\u00a0to\u00a0operate\u00a0solely\u00a0on\u00a0electricity.\u00a0To make this changeover\u00a0feasible,\u00a0it is\u00a0working\u00a0with\u00a0Wheels to\u00a0build\u00a0a solution\u00a0that includes\u00a0everything from\u00a0vehicle acquisition\u00a0to\u00a0driver support.\u00a0\u00a0<\/p>\r\n\r\n\r\n\r\n
The company\u00a0has\u00a0adjusted\u00a0their overall fleet budget\u00a0to\u00a0achieve\u00a0their\u00a0long-term\u00a0sustainability goals. To\u00a0help\u00a0offset,\u00a0they follow a consistent replacement strategy\u00a0of 36 months or 65,000 miles\u00a0which\u00a0helps\u00a0keep\u00a0their\u00a0maintenance costs low\u00a0and driver satisfaction high.\u00a0Additionally, replacing vehicles\u00a0quickly\u00a0helps fast track their electrification goals.\u00a0\u00a0<\/p>\r\n\r\n\r\n\r\n
The company is well on their way to 100% fleet electrification; they now only select hybrid or fully electric vehicles as part of their optimal replacement strategy and have already converted 56% of their active fleet inventory.\u00a0<\/p>\r\n\r\n\r\n\r\n
Since January of 2010, the fleet\u2019s fuel economy leapt 31%, from 22 to 29 MPG. That transformation drove a reduction of nearly 50%<\/strong> in CO2 emissions \u2014 a savings equivalent to planting over 30,000 trees.<\/p>\r\n","protected":false},"excerpt":{"rendered":" Opportunity A leading biotechnology provider set a corporate goal to slash emissions throughout its operations. Part of that initiative,\u00a0driven\u00a0through its involvement in the EV100 initiative, is to convert its sales fleet of more than 1,300 vehicles to\u00a0electric vehicles (EVs)\u00a0by 2030, translating to an ambitious move toward vehicle electrification. Strategy It has already made enormous strides […]<\/p>\n","protected":false},"author":52,"featured_media":22989219,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"project_category":[24],"project_tag":[],"class_list":["post-4304","project","type-project","status-publish","has-post-thumbnail","hentry","project_category-success-stories","topics-electric-vehicles","topics-vehicle-acquisition"],"acf":[],"yoast_head":"\n